EUVIMEDEUVIMED entdecken
Crossref

An Effective Reaction‐Based Virtual Screening Method to Discover New CDK8 Ligands

Wei Chen iD, Hanlin Fang, Huan He, Jing Ping, Jianxin Ge

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400825 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Wei Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fuzhou Medical College of NanChang University, Fuzhou, JiangXi, 344000, China. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 8, Protein Kinase Inhibitors, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Education Department of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin Dependent Kinase 8 (CDK8) is a valuable drug target for cancer suppression. Through an effective reaction‐based virtual screening method consisting of pharmacophore modeling, Scifinder database searches, and energy evaluations, a number of new type II CDK8 ligands were discovered with comparable or better binding free energies than the ones reported in literature. In this method, a pharmacophore model, derived from seven crystal structures of CDK8 and type II ligands, was able to catch the key interactions for ligands binding at the ATP binding site of CDK8. This model then was used to screen the results from Scifinder database searches that apply chemical reaction rules in the search cycles, and the output compounds were evaluated and ranked first by a fast energy estimation method and then by the VM2 free energy calculation method. Among the top discovered ligands, three have lower K d values against CDK8 than a potent reference ligand, and compound F (3‐[3‐tert‐butyl‐1‐(4‐methylphenyl)‐1H‐pyrazol‐5‐yl]‐1‐(8‐hydroxynaphthalen‐1‐yl)urea) is the most potent one with an K d value of 7.5 nM. Compound F has a relatively small molecular structure, receives both strong van der Waals energy and optimized overall electrostatic energy when binding with CDK8, and deserves to be a promising lead compound for further development. This effective virtual screening method and the novel compounds found in this work have implications for CDK8 drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase 8Protein Kinase InhibitorsDrug DiscoveryLigandsHumansBinding SitesMolecular StructureStructure-Activity RelationshipDrug Evaluation, PreclinicalModels, Molecular

Stichwörter der Autor:innen

CDK8 inhibitorbinding thermodynamicscomputer-aided drug designdrug discoverypharmacophore

Substanzen

LigandsCyclin-Dependent Kinase 8Protein Kinase InhibitorsCDK8 protein, human

Autor:innen und Institutionen

  • School of Pharmacy, Fuzhou Medical College of NanChang University, Fuzhou, JiangXi, 344000, China.
  • Key Laboratory of AI-Powered Innovation in Drug Discovery of Jiangxi Education Institutes, Fuzhou, JiangXi, 344000, China.
  • Fuzhou Ecological Environment Technology Support Center, Fuzhou, JiangXi, 344000, China.

ORCID-Profile: Wei Chen

Förderung

  • Education Department of Jiangxi Province

Zitieren

APA

Chen, W., Fang, H., He, H., Ping, J., & Ge, J. (2025). An Effective Reaction‐Based Virtual Screening Method to Discover New CDK8 Ligands. ChemMedChem. https://doi.org/10.1002/cmdc.202400825

Vancouver

Chen W, Fang H, He H, Ping J, Ge J. An Effective Reaction‐Based Virtual Screening Method to Discover New CDK8 Ligands. ChemMedChem. 2025. doi:10.1002/cmdc.202400825

BibTeX
@article{Chen2025,
  author = {Chen, Wei and Fang, Hanlin and He, Huan and Ping, Jing and Ge, Jianxin},
  title = {An Effective Reaction‐Based Virtual Screening Method to Discover New CDK8 Ligands},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400825}
}
Kostenlos starten →